BIOLASE develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners. The company’s principal products are revolutionary dental laser systems, making it the world’s leading manufacturer and distributor of dental lasers.

The company announced today that the U.S. Patent and Trademark Office issued it a new patent covering the use of its laser technologies for treating various conditions of the eye, including cataracts, glaucoma, and presbyopia. The patent significantly broadens the claims for the patent family and anticipates using complimentary technologies to streamline procedures to identify the rigidity of the eye to optimize treatment locations in presbyopia procedures, for example.

The latest patent grant is the tenth U.S. patent issued under the “Methods for Treating Eye Conditions” patent family. Three other patents have been issued internationally and six more are pending worldwide. BIOLASE now holds a total of 20 issued and 20 pending U.S. and international patents in seven patent families in the field of ophthalmology. The patents give the company and its OCCULASE subsidiary a wide range of potential applications and coverage in the field.

This new patent is important for the company and its innovative WaterLase technology. Marcia Van Valen, director of business development for BIOLASE, said the patent further leverages the firm’s technology and broadens the patent family “to allow the laser parameters and groupings of tissue treatment to compensate for correlation in the various layers in ocular tissue for treating eye conditions such as presbyopia, cataract and glaucoma.”

For additional information about BIOLASE and its laser technologies, please visit www.biolase.com

Let us hear your thoughts below: